Aniara | Shaping the Future with Innovative Solutions

Aniara Grant

Coagulation Research Grant | 2016


Aniara Diagnostica's Coagulation Research Grant provides $10,000 for established investigators (eg - faculty at an academic institution) and for students/trainees to do innovative coagulation/hematology reseach. Deadline for receipt of application is November 1, 2016.

The Aniara Reseach Panel awards one yearly $10,000 grant for specialized in hematology and coagulation research. All proposed projects must be in the coagulation/hematology scientific field.


This year, we’re asking for projects that deal specifically with EDS — Ehlers-Danlos syndrome — and its effects on hemostasis and thrombosis. Extensive bruising, spontaneous arterial rupture, rupture of hollow organs, and severe internal bleeding are predominant features in EDS. Patients suffering from such syndromes typically undergo hematological studies including evaluation of clotting factors, platelet aggregation, and bleeding time.

Aniara has a passionate interest in this research because one of our own family suffers from EDS. We hope the grant will be used to spread awareness of this disease and address its specific issues within the hemostasis and coagulation fields.


Funding is restricted to North America, South America, Latin America, and Nordic countries.. This grant program does not pay educational tuition, nor does it offer scholarships or fellowships of any kind.


Applicants are expected to have advanced degrees (Ph.D. or equivalent) and be associated with an educational organization or institution. Independent researchers or those pursuing a Ph.D.-level degree may apply, but awards to non-PhD. applicants are rare. As a general rule, all applicants are expected to have published a minimum of three articles in peer-reviewed scientific journals.

Grant Amount

ANIARA will award one $10,000.00 grant recipient per year.

Grant Restrictions

Aniara Coagulation Research Grants may not be used for indirect costs, overhead, and other expenses not directly related to the project. Fringe benefits are also excluded, as are salaries.

Funds may not be used for travel to scientific/professional meetings or conferences, legal actions, land acquisition, endowments, construction of permanent field stations, or publishing research results.

Thank you for applying.

Click Here to View/Print Aniara Coagulation Research Grant Brochure


View Video





2013-Luigi Brunetti, PharmD, MPH, BCPS, CGP
2012 - Dr. Chad M. Paton, Ph.D

2010 - Leonardo R. Brandao, MD
2009 - Dr. Mirta Schattner, Ph.D.
2008 - Dr. Graciela Krikun, Ph.D.
2007 - Dr. Margaret Prechel, Ph.D.
2006 - Dr. A. Valance Washington, Ph.D.

Scientific Advisors

Dr. Dorothy Adcock
Medical Director/Laboratory Director Colorado Coagulation Consultants, INc, dba Esoterix Coagulation Denver, Colorado.

Dr. Kenneth A. Bauer
Professory of Medicine, Harvard Medical School. His hospital positions include Chief, Hematology Section, VA Boston Healthcare System, and Director, Thrombosis Clinical Research, Beth Israel Deaconess Medical Center.

Dr. Charles S. Eby
Associate Director of Educational Programs, Division of Laboratory Medicine at Washington University Saint Louis, Member of Barnes-Jewish Hospital Credentialing and Health Information Management Committees.

Dr. Andreas Hillarp
Position as hospital chemist at the Department of Clinical Chemistry, University Hospital, Malm, Sweden.

Dr. Mervyn A. Sahud, M.D., A.B.I. M.-Hem.
Medical Director Coagulation Department Quest Diagnostics Nichols Institute.

Dr. Sam Schulman
Associate professor in Internal Medicine at Karolinska Institute and since September 2004 also professor in medicine at McMaster University.

Agneta Siegbahn, MD, Ph.D.
Professor in Clinical Coagulation Science Department of Medical Sciences, Clinical Chemistry Akademiska Hospital, Uppsala, Sweden.

Jogin R. Wu, Ph.D.
Associate Clinical Professor of Pathology, Duke University Medical Center. Associate Director, Clinical Coagulation Laboratory, Duke University Health System.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.